220 related articles for article (PubMed ID: 9017160)
1. Immunomodulatory activity of conformationally restricted peptides related to TGF-beta-2 90-99 sequence.
Wieczorek Z; Słoń JJ; Siemion IZ
Arch Immunol Ther Exp (Warsz); 1996; 44(4):209-14. PubMed ID: 9017160
[TBL] [Abstract][Full Text] [Related]
2. Immunosuppressive activity of some peptides related to cycloamanide A (CyA A) and to the active fragment of a peptide immunomodulator from ovine colostrum.
Bolewska-Pedyczak E; Wieczorek Z; Zimecki M; Siemion IZ
Arch Immunol Ther Exp (Warsz); 1993; 41(5-6):297-301. PubMed ID: 8010869
[TBL] [Abstract][Full Text] [Related]
3. Novel sst(4)-selective somatostatin (SRIF) agonists. 3. Analogues amenable to radiolabeling.
Erchegyi J; Waser B; Schaer JC; Cescato R; Brazeau JF; Rivier J; Reubi JC
J Med Chem; 2003 Dec; 46(26):5597-605. PubMed ID: 14667214
[TBL] [Abstract][Full Text] [Related]
4. Complete covalent structure of human platelet factor 4.
Morgan FJ; Begg GS; Chesterman CN
Thromb Haemost; 1980 Feb; 42(5):1652-60. PubMed ID: 6445090
[TBL] [Abstract][Full Text] [Related]
5. Novel sst(4)-selective somatostatin (SRIF) agonists. 2. Analogues with beta-methyl-3-(2-naphthyl)alanine substitutions at position 8.
Erchegyi J; Penke B; Simon L; Michaelson S; Wenger S; Waser B; Cescato R; Schaer JC; Reubi JC; Rivier J
J Med Chem; 2003 Dec; 46(26):5587-96. PubMed ID: 14667213
[TBL] [Abstract][Full Text] [Related]
6. The immunosuppressive mini-domain of human lactoferrin.
Siemion IZ; Sloń J; Wieczorek Z
J Pept Sci; 1995; 1(5):295-302. PubMed ID: 9223008
[TBL] [Abstract][Full Text] [Related]
7. Copper(I) interaction with model peptides of WD6 and TM6 domains of Wilson ATPase: regulatory and mechanistic implications.
Myari A; Hadjiliadis N; Fatemi N; Sarkar B
J Inorg Biochem; 2004 Sep; 98(9):1483-94. PubMed ID: 15337600
[TBL] [Abstract][Full Text] [Related]
8. Myasthenogenicity of human acetylcholine receptor synthetic alpha-subunit peptide 125-147 does not require intramolecular disulfide cyclization.
McCormick DJ; Griesmann GE; Huang ZX; Lambert EH; Lennon VA
J Immunol; 1987 Oct; 139(8):2615-9. PubMed ID: 3498765
[TBL] [Abstract][Full Text] [Related]
9. The analgesic activity of some tuftsin- and tuftsin inhibitor-like fragments of the viral coat proteins.
Obuchowicz E; Słoń JJ; Klin M; Madej A; Siemion IZ; Herman ZS
Pol J Pharmacol; 1993; 45(3):269-79. PubMed ID: 8220660
[TBL] [Abstract][Full Text] [Related]
10. Influence of Lys-residue deletion on the immunomodulatory activity of peptides related to immunosuppressive region of lactoferrin.
Słoń JI; Siemion IZ; Zimecki M; Wieczorek Z
Arch Immunol Ther Exp (Warsz); 1995; 43(3-4):211-6. PubMed ID: 8744698
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and biological studies on analogs of cyclolinopeptide A with a shortened peptide chain.
Siemion IZ; Pedyczak A; Strug I; Wieczorek Z
Arch Immunol Ther Exp (Warsz); 1994; 42(5-6):459-65. PubMed ID: 8572907
[TBL] [Abstract][Full Text] [Related]
12. Design and synthesis of potent, highly selective vasopressin hypotensive agonists.
Stoev S; Cheng LL; Manning M; Wo NC; Szeto HH
J Pept Sci; 2006 Sep; 12(9):592-604. PubMed ID: 16625682
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and immunosuppressive activity of glycine containing linear analogs of cyclolinopeptide A.
Siemion IZ; Cebrat M; Pédyczak A; Zimecki M; Wieczorek Z
Arch Immunol Ther Exp (Warsz); 1993; 41(5-6):285-9. PubMed ID: 8010867
[TBL] [Abstract][Full Text] [Related]
14. Further investigations on thymopentin-like fragments of HLA-DQ and their analogs.
Szewczuk Z; Wieczorek Z; Stefanowicz P; Wilczyński A; Siemion IZ
Arch Immunol Ther Exp (Warsz); 1997; 45(4):335-41. PubMed ID: 9523010
[TBL] [Abstract][Full Text] [Related]
15. Secondary structure of a dynamic type I'beta-hairpin peptide.
Stotz CE; Borchardt RT; Middaugh CR; Siahaan TJ; Vander Velde D; Topp EM
J Pept Res; 2004 Apr; 63(4):371-82. PubMed ID: 15102055
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and biological effects of c(Lys-Lys-Pro-Tyr-Ile-Leu-Lys-Lys-Pro-Tyr-Ile-Leu) (JMV2012), a new analogue of neurotensin that crosses the blood-brain barrier.
Bredeloux P; Cavelier F; Dubuc I; Vivet B; Costentin J; Martinez J
J Med Chem; 2008 Mar; 51(6):1610-6. PubMed ID: 18321036
[TBL] [Abstract][Full Text] [Related]
17. Structure-activity relationship studies optimizing the antiproliferative activity of novel cyclic somatostatin analogues containing a restrained cyclic beta-amino acid.
Sukopp M; Schwab R; Marinelli L; Biron E; Heller M; Várkondi E; Pap A; Novellino E; Kéri G; Kessler H
J Med Chem; 2005 Apr; 48(8):2916-26. PubMed ID: 15828830
[TBL] [Abstract][Full Text] [Related]
18. Immunosuppressive activity of C-terminal fragments of tachykinins.
Siemion IZ; Kubik A; Zimecki M; Wieczorek Z
Arch Immunol Ther Exp (Warsz); 1994; 42(3):201-3. PubMed ID: 7487353
[TBL] [Abstract][Full Text] [Related]
19. Immunosuppressive activity of alanine analogs of cyclolinopeptide A.
Wieczorek Z; Zimecki M; Pedyczak A; Lisowski M; Siemion IZ
Arch Immunol Ther Exp (Warsz); 1993; 41(5-6):291-6. PubMed ID: 8010868
[TBL] [Abstract][Full Text] [Related]
20. Immunosuppressive activity of analogs of tripeptide Lys-Arg-Pro with D-amino acid residues.
Siemion IZ; Kluczyk A; Słoń JJ; Zimecki M; Wieczorek Z
Arch Immunol Ther Exp (Warsz); 1994; 42(3):205-7. PubMed ID: 7487354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
